期刊文献+

甲巯咪唑致重度粒细胞缺乏1例 被引量:1

One case of severe agranulocytosis induced by methimazole
下载PDF
导出
摘要 1例65岁男性患者,1个月前诊断为甲状腺功能亢进症,规律服用甲巯咪唑20 mg·d^(-1)治疗。期间无规律复查血常规。4 d前患者出现发热、咳嗽、咽痛等症状,未诊治。上述症状反复,复查血常规示:白细胞1.76×109·L^(-1),中性粒细胞0.01×10~9·L^(-1),伴发热,诊断为"粒细胞缺乏症"。遂停用甲巯咪唑,保护性隔离,并给予"重组人粒细胞刺激因子、地榆升白片"升高白细胞,同时积极给予经验性抗感染治疗。期间患者反复出现高热、咽痛、腹泻等症状,监测血常规提示连续1周粒细胞为零,根据病情调整重组人粒细胞刺激因子剂量,根据病原学结果调整抗感染治疗方案,治疗13 d后,患者白细胞及中性粒细胞逐渐升至正常范围,病情稳定。 One 65-year-old male patient was diagnosed with hyperthyroidism a month ago.The patient was regularly treated with methimazole 20 mg·d^-1.While,blood routine examination was rechecked irregularly during the treatment.Four days ago,the patient had fever,cough,sore throat and other symptoms,with no diagnosis and treatment.The symptoms above repeatedly manifested.Blood routine examination showed that white blood cell count was 1.76 × 10^9·L^-1,neutrophils count was 0.01 × 10^9·L^-1,which was diagnosed with agranulocytosis.Then methimazole was stopped.The protective isolation,recombinant human G-CSF and Diyushengbai tablets for increasing white blood cell count were used.As well as anti-infective therapy were also given.During the period,high fever,sore throat,diarrhea and other symptoms occurred frequently.Blood routine examination showed that the neutrophils count was zero for a week.Then according to the patient's condition,the dosage of recombinant human G-CSF was adjusted,and the anti-infective treatment regimen was adjusted according to the results of pathogens.White blood cell count and neutrophils count recovered to normal range after the 13-day treatment.The condition of patient was stable.
作者 朱满刚 李俊
出处 《中国药物应用与监测》 CAS 2017年第5期324-326,共3页 Chinese Journal of Drug Application and Monitoring
基金 广东省科技计划项目(20130319c)
关键词 甲巯咪唑 甲状腺功能亢进症 粒细胞缺乏症 药品不良反应 Methimazole Hyperthyroidism Agranulocytosis Adverse drug reaction
  • 相关文献

参考文献10

二级参考文献63

  • 1蔡晓频,杨文英,杨兆军,陈燕燕,卜石.抗甲状腺药物致粒细胞缺乏症6例临床分析[J].中国实用内科杂志,2005,25(8):731-732. 被引量:12
  • 2陈新谦,金有豫,汤光.新编药物学[M].17版.北京:人民卫生出版社,2011:3465. 被引量:845
  • 3姜晓华,顾卫琼,宁光.甲亢伴发热、白细胞减少[N].中国医学论坛报,2010-2-4,(A8). 被引量:2
  • 4中国甲状腺疾病诊治指南——甲状腺功能亢进症[J].中华内科杂志,2007,46(10):876-882. 被引量:856
  • 5Bastuji-Garin S, Rzany B, Stem RS, et al. Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme[J]. Arch Dermatol, 1993, 129(1): 92-96. 被引量:1
  • 6Schneck J, Fagot JP, Sekula P, et al. Effects of treatments on the mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis: a retrospective study on patients included in the prospective EuroSCAR Study[J]. J Am Acad Dermatol, 2008, 58(1): 33-40. 被引量:1
  • 7Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions[J]. Clin Pharmacol Ther, 1981, 30(2): 239-245. 被引量:1
  • 8Sassolas B, Haddad C, Mockenhaupt M, et al. ALDEN, an algorithm for assessment of drug causality in Stevens-Johnson syndrome and toxic epidermal necrolysis: comparison with case- control analysis[J]. Clin Pharmacol Ther, 2010, 88(1): 60-68. 被引量:1
  • 9Roujeau JC, Kelly JP, Naldi L, et al. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis[J]. N Engl J Med, 1995, 333(24): 1600-1607. 被引量:1
  • 10Mockenhaupt M, Viboud C, Dunant A, et al. Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marked drugs. The EuroSCAR-study[J]. J Invest Dermatol, 2008, 128(1): 35-44. 被引量:1

共引文献107

同被引文献8

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部